Ascendis Pharma

Biotech

Denmark

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 2 drugs with upcoming expirations

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

HQDenmark

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Regulatory

20241 event

FDAAug 9

Yorvipath — YORVIPATH

Application NDA216490 (NDA)

20261 event

FDAFeb 27

Yuviwel — YUVIWEL

Application NDA219164 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)